Author:
Chermá Maria D,Reis Margareta,Hägg Staffan,Ahlner Johan,Bengtsson Finn
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference27 articles.
1. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.;Seeger;J Pharmacol Exp Ther,1995
2. The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone.;Hamelin;Pharmacotherapy,1998
3. Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.;Miceli;Br J Clin Pharmacol,2000
4. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.;Prakash;Drug Metab Dispos,1997
5. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.;Prakash;Br J Clin Pharmacol,2000
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献